5[1]Alberts SR, Cervantes A, van de Velde CJH. Gastric cancer:Epidemiology, pathology and treatment. Annals of Oncology,2003, 14 (Suppl 2) :ii31 被引量：1
6[2]Frederick LG, David LP, Irvin DF, et al. AJCC Cancer Staging Manual. 6th. ed, New York: Springer, 2002, 99 被引量：1
7[3]Hundahl SA, Menck HR, Mansour EG, et al. The national cancer database report on gastric carcinoma. Cancer, 1997, 80: 2333 被引量：1
8[4]Spataro V, Genoni M, Maurer C, et al. Stomach cancer: 10years' experience with surgical treatment and possibilities for improving the prognosis. Helv Chir Acta, 1993, 59:589 被引量：1
9[5]Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 2001, 345:725 被引量：1
10[6]Bajetta E, Buzzoni R, Mariani E, et al. Adjuvant chemotherapy in gastric cancer: 5 - year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology, 2002, 13:299 被引量：1
6Chu DZ,Lang NP,Thompson C,et al.Perioneal carcinomatosis in nongynecologic malignancy.a prospective study of prognostic factors[J].Cancer,1989,63(2):364-7. 被引量：1
7Sadeghi B,Arvieux C,Glehen O,et al.Peritoneal carcinomatosis from non-gynecologic malignancies:results of the EVOCAPE 1 multicentric prospective study[J].Cancer,2000,88(2):358-63. 被引量：1
9Seymour MT,Trigonis L,Finan PJ,et al.A feasibility,pharmacokinetic and frequency-escalation trial of intraperitoneal chemotherapy in high risk gastrointestinal tract cancer[J].EJSO,2008,34(4):403-9. 被引量：1
10Martin S.Treatment of Pancreatic Exocrine Deficiency[J].World J Surg,2003,27(11):1192-5. 被引量：1
